These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 19583780

  • 21. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias.
    Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, Aronica E.
    Epilepsia; 2010 Sep; 51(9):1763-73. PubMed ID: 20345941
    [Abstract] [Full Text] [Related]

  • 23. Imbalance of interneuron distribution between neocortex and basal ganglia: consideration of epileptogenesis of focal cortical dysplasia.
    Sakakibara T, Sukigara S, Otsuki T, Takahashi A, Kaneko Y, Kaido T, Saito Y, Sato N, Nakagawa E, Sugai K, Sasaki M, Goto Y, Itoh M.
    J Neurol Sci; 2012 Dec 15; 323(1-2):128-33. PubMed ID: 22989610
    [Abstract] [Full Text] [Related]

  • 24. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis.
    Becker AJ, Urbach H, Scheffler B, Baden T, Normann S, Lahl R, Pannek HW, Tuxhorn I, Elger CE, Schramm J, Wiestler OD, Blümcke I.
    Ann Neurol; 2002 Jul 15; 52(1):29-37. PubMed ID: 12112044
    [Abstract] [Full Text] [Related]

  • 25. Cortical neuronal densities and lamination in focal cortical dysplasia.
    Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM.
    Acta Neuropathol; 2005 Oct 15; 110(4):383-92. PubMed ID: 16151726
    [Abstract] [Full Text] [Related]

  • 26. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.
    Yao K, Duan Z, Zhou J, Li L, Zhai F, Dong Y, Wang X, Ma Z, Bian Y, Qi X, Li L.
    Oncotarget; 2016 Nov 22; 7(47):76415-76422. PubMed ID: 27811355
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
    Knerlich-Lukoschus F, Connolly MB, Hendson G, Steinbok P, Dunham C.
    J Neurosurg Pediatr; 2017 Feb 22; 19(2):182-195. PubMed ID: 27885945
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Doublecortin (DCX) and doublecortin-like (DCL) are differentially expressed in the early but not late stages of murine neocortical development.
    Boekhoorn K, Sarabdjitsingh A, Kommerie H, de Punder K, Schouten T, Lucassen PJ, Vreugdenhil E.
    J Comp Neurol; 2008 Apr 01; 507(4):1639-52. PubMed ID: 18231966
    [Abstract] [Full Text] [Related]

  • 33. Doublecortin expression in the normal and epileptic adult human brain.
    Liu YW, Curtis MA, Gibbons HM, Mee EW, Bergin PS, Teoh HH, Connor B, Dragunow M, Faull RL.
    Eur J Neurosci; 2008 Dec 01; 28(11):2254-65. PubMed ID: 19046368
    [Abstract] [Full Text] [Related]

  • 34. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
    Li S, Zang Z, He J, Chen X, Yu S, Pei Y, Hou Z, An N, Yang H, Zhang C, Liu S.
    Oncotarget; 2017 Jan 24; 8(4):6883-6895. PubMed ID: 28036289
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Doublecortin expression in adult cat and primate cerebral cortex relates to immature neurons that develop into GABAergic subgroups.
    Cai Y, Xiong K, Chu Y, Luo DW, Luo XG, Yuan XY, Struble RG, Clough RW, Spencer DD, Williamson A, Kordower JH, Patrylo PR, Yan XX.
    Exp Neurol; 2009 Apr 24; 216(2):342-56. PubMed ID: 19166833
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
    Boer K, Middeldorp J, Spliet WG, Razavi F, van Rijen PC, Baayen JC, Hol EM, Aronica E.
    Epilepsy Res; 2010 Jun 24; 90(1-2):99-109. PubMed ID: 20430588
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy.
    Hadjivassiliou G, Martinian L, Squier W, Blumcke I, Aronica E, Sisodiya SM, Thom M.
    Acta Neuropathol; 2010 Oct 24; 120(4):517-28. PubMed ID: 20411268
    [Abstract] [Full Text] [Related]

  • 40. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Yu SX, Li S, Shu HF, Zhang CQ, Liu SY, Yang H.
    J Neuropathol Exp Neurol; 2012 Jul 24; 71(7):665-77. PubMed ID: 22710967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.